New Cancer Vaccine Implant from Harvard Reprograms Our Cells
In brief: An implantable cancer vaccine from Harvard has already shown promising results in mice, and researchers are testing it in a clinical trial on humans. [This article first appeared on LongevityFacts. Author: Brady Hartman. ] An implantable cancer vaccine being tested on patients by Harvard’s Wyss Institute is a new type of immunotherapy that holds promise to treat a wide range of cancers… Continue reading "New Cancer Vaccine Implant from Harvard Reprograms Our Cells"